Company news

Aptamer Group PLC news in 2024

Aptamer Group PLC's news releases, calls and decks from 2024, newest first.

View company

New Development Contract

December 19, 2024

Grant of Options and Director Fee Shares

December 9, 2024

New Scientific Advisory Board Members

December 6, 2024

Technical Update

December 5, 2024

Results of 2024 Annual General Meeting

November 29, 2024

Agreement extended with genetic medicines customer

November 7, 2024

Commercial Trading Update

November 6, 2024

Full Year Results for the 12mths to 30 June 2024

October 22, 2024

Director Appointment

September 16, 2024

Aptamer extends contract with Unilever

September 3, 2024

Block listing Interim Review

August 27, 2024

Result of General Meeting and Board Changes

August 13, 2024

Supplementary Conditional Placing for £60,000

August 1, 2024

Fundraise to Raise £2.83 million

July 24, 2024

Update on progress in Unilever partnership

July 8, 2024

Agreement to explore Optimer vehicles for siRNA

July 3, 2024

New Contracts Announcement for Optimer Development

June 24, 2024

Partnership with Microsaic Systems

June 14, 2024

New contracts with top ten pharma partners

May 23, 2024

Aptamer and Timser Partnership

May 22, 2024

Holding(s) in Company - REPLACEMENT

April 23, 2024

Top Pharma Company evaluates Optimer for medicine

April 22, 2024

TR-1: Notification of major holdings

April 18, 2024

Aptamer and Kairos Biotech partner for Optimer+

April 18, 2024

Patent submission for Optimer® binders

April 8, 2024

Notice of Interim Results & Investor Presentation

March 22, 2024

Aptamer Progresses Partnership with Unilever

March 11, 2024

R&D progress on new Optimer®+ platform

February 27, 2024

Second Phase of Alzheimer's test with Neuro-Bio

February 22, 2024

Calls in 2024

Decks in 2024